Temporal trends in 90-day survival of hospitalised individuals during two years of the COVID-19 pandemic in Denmark

References

• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of covid-19 – Final report. N Engl J Med. 2020;383(19):1813–1826. doi: 10.1056/NEJMoa2007764.
   PubMed Web of Science ®Google Scholar
• Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384(8):693–704. doi: 10.1056/NEJMoa2021436.
   PubMed Web of Science ®Google Scholar
• RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397(10285):1637–1645. doi: 10.1016/S0140-6736(21)00676-0.
   PubMed Web of Science ®Google Scholar
• Gordon AC, Mouncey PR, Al-Beidh F, et al. Interleukin-6 receptor antagonists in critically ill patients with covid-19. N Engl J Med. 2021;384(16):1491–1502. doi: 10.1056/NEJMoa2100433.
   PubMed Web of Science ®Google Scholar
• Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus pandemic (COVID-19). 2020. Published online at OurWorldInData.org
   Google Scholar
• Moon RC, Mackey RH, Cao Z, et al. Is coronavirus disease 2019 (COVID-19) less deadly now? Trends in in-hospital mortality among hospitalized COVID-19 patients in the United States. Clin Infect Dis. 2022;74(12):2238–2242. doi: 10.1093/cid/ciab830.
   PubMed Web of Science ®Google Scholar
• Horwitz LI, Jones SA, Cerfolio RJ, et al. Trends in COVID-19 risk-adjusted mortality rates. J Hosp Med. 2021;16(2):90–92. doi: 10.12788/jhm.3552.
   PubMed Web of Science ®Google Scholar
• Asch DA, Sheils NE, Islam MN, et al. Variation in US hospital mortality rates for patients admitted with COVID-19 During the first 6 months of the pandemic. JAMA Intern Med. 2021;181(4):471–478. doi: 10.1001/jamainternmed.2020.8193.
   PubMed Web of Science ®Google Scholar
• Bennett TD, Moffitt RA, Hajagos JG, et al. Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the US national COVID cohort collaborative. JAMA Netw Open. 2021;4(7):e2116901. doi: 10.1001/jamanetworkopen.2021.16901.
   PubMed Web of Science ®Google Scholar
• Jones S, Mason N, Palser T, et al. Trends in risk-adjusted 28-day mortality rates for patients hospitalized with COVID-19 in England. J Hosp Med. 2021;16(5):290–293. doi: 10.12788/jhm.3599.
   PubMed Web of Science ®Google Scholar
• Roth GA, Emmons-Bell S, Alger HM, et al. Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic. JAMA Netw Open. 2021;4(5):e218828. doi: 10.1001/jamanetworkopen.2021.8828.
   PubMed Web of Science ®Google Scholar
• Benfield T, Bodilsen J, Brieghel C, et al. Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study. Clin Infect Dis. 2021;73(11):2031–2036. doi: 10.1093/cid/ciab536.
   PubMed Web of Science ®Google Scholar
• Ghelichkhani P, Esmaeili M. Prone position in management of COVID-19 patients; a commentary. Arch Acad Emerg Med. 2020;8:e48.
   PubMedGoogle Scholar
• COVID-19 Treat Guidelines. Oxygenation and ventilation for adults. 2023 [cited 2023 Jan 17]. https://www.covid19treatmentguidelines.nih.gov/management/critical-care-for-adults/oxygenation-and-ventilation-for-adults/
   Google Scholar
• Mellado-Artigas R, Ferreyro BL, Angriman F, et al. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Crit Care. 2021;25(1):58. doi: 10.1186/s13054-021-03469-w.
   PubMed Web of Science ®Google Scholar
• Ehrmann S, Li J, Ibarra-Estrada M, et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021;9(12):1387–1395. doi: 10.1016/S2213-2600(21)00356-8.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi: 10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Danish Covid-19 Genome Consortium. Genomic overview of SARS-CoV-2 in Denmark. 2022. https://www.covid19genomics.dk/statistics.
   Google Scholar
• Fiore MC, Smith SS, Adsit RT, et al. The first 20 months of the COVID-19 pandemic: mortality, intubation and ICU rates among 104,590 patients hospitalized at 21 United States health systems. PLOS One. 2022;17(9):e0274571. doi: 10.1371/journal.pone.0274571.
   PubMed Web of Science ®Google Scholar
• Alharbi A-HM, Rabbani SI, Halim Mohamed AA, et al. Analysis of potential risk factors associated with COVID-19 and hospitalization. Front Public Health. 2022;10:921953. doi: 10.3389/fpubh.2022.921953.
   PubMed Web of Science ®Google Scholar
• Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi: 10.1016/S0140-6736(20)31189-2.
   PubMed Web of Science ®Google Scholar
• Rosenthal N, Cao Z, Gundrum J, et al. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
   PubMed Web of Science ®Google Scholar
• Tenforde MW, Self WH, Adams K, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(20):2043–2054. doi: 10.1001/jama.2021.19499.
   PubMed Web of Science ®Google Scholar
• Naouri D, Vuagnat A, Beduneau G, et al. Trends in clinical characteristics and outcomes of all critically ill COVID-19 adult patients hospitalized in France between march 2020 and june 2021: a national database study. Ann Intensive Care. 2023;13(1):2. doi: 10.1186/s13613-022-01097-3.
   PubMed Web of Science ®Google Scholar
• Moffa MA, Shively NR, Walsh TL. Characteristics of postvaccination coronavirus disease 2019 hospitalizations prior to booster vaccines. Open Forum Infect Dis. 2022;9(4):ofac014. doi: 10.1093/ofid/ofac014.
   PubMed Web of Science ®Google Scholar
• Mozaffari E, Chandak A, Zhang Z, et al. Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort. Clin Infect Dis. 2022;75(1):e450–e458. doi: 10.1093/cid/ciab875.
   PubMed Web of Science ®Google Scholar
• Marx K, Gončarova K, Fedders D, et al. Clinical outcomes of hospitalized COVID-19 patients treated with remdesivir: a retrospective analysis of a large tertiary care center in Germany. Infection. 2023;51(1):97–108. doi: 10.1007/s15010-022-01841-8.
   PubMed Web of Science ®Google Scholar
• Diaz GA, Christensen AB, Pusch T, et al. Remdesivir and mortality in patients With coronavirus disease 2019. Clin Infect Dis. 2022;74(10):1812–1820. doi: 10.1093/cid/ciab698.
   PubMed Web of Science ®Google Scholar
• Beckerman R, Gori A, Jeyakumar S, et al. Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis. Sci Rep. 2022;12(1):9622. doi: 10.1038/s41598-022-13680-6.
   PubMed Web of Science ®Google Scholar
• Petrone D, Mateo-Urdiales A, Sacco C, et al. Reduction of the risk of severe COVID-19 due to omicron compared to Delta variant in Italy (November 2021 – February 2022). Int J Infect Dis. 2023;129:135–141. doi: 10.1016/j.ijid.2023.01.027.
   PubMed Web of Science ®Google Scholar
• Ward IL, Bermingham C, Ayoubkhani D, et al. Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with Delta (B.1.617.2): retrospective cohort study. The BMJ. 2022;378:e070695. doi: 10.1136/bmj-2022-070695.
   PubMedGoogle Scholar
• Maslo C, Friedland R, Toubkin M, et al. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 omicron wave compared with previous waves. JAMA. 2022;327(6):583–584. doi: 10.1001/jama.2021.24868.
   PubMed Web of Science ®Google Scholar
• Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437–446. doi: 10.1016/S0140-6736(22)00017-4.
   PubMed Web of Science ®Google Scholar
• Friis NU, Martin-Bertelsen T, Pedersen RK, et al. COVID-19 mortality attenuated during widespread omicron transmission, Denmark, 2020 to 2022. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2023;28(3):2200547. doi: 10.2807/1560-7917.ES.2023.28.3.2200547.
   PubMedGoogle Scholar